Potential of Ayurgenomics Approach in Complex Trait Research: Leads from a Pilot Study on Rheumatoid Arthritis

PLoS ONE

Volumn 7, Issue 9, 2012, Pages

  Juyal, Ramesh C ^a   Negi, Sapna ^a   Wakhode, Preeti ^b   Bhat, Sulekha ^b   Bhat, Bheema ^b   Thelma, B K ^c  

^a NATIONAL INSTITUTE OF IMMUNOLOGY   (India)

^b Holy Family Hospital   (India)

^c UNIVERSITY OF DELHI   (India)

Author keywords

[No Author keywords available]

Indexed keywords

ARYLDIALKYLPHOSPHATASE 1; CD40 ANTIGEN; EXTRACELLULAR SUPEROXIDE DISMUTASE; INTERLEUKIN 1BETA; TUMOR NECROSIS FACTOR ALPHA;

ADULT; ARTICLE; AYURGENOMICS; AYURVEDA; CASE CONTROL STUDY; CD40 GENE; COHORT ANALYSIS; CONTROLLED STUDY; FEMALE; GENE; GENETIC ANALYSIS; GENETIC MARKER; GENETIC SUSCEPTIBILITY; GENOMICS; GENOTYPE; HAPLOTYPE; HUMAN; IL1B GENE; INFLAMMATION; MAJOR CLINICAL STUDY; MALE; OXIDATIVE STRESS; PON1 GENE; RHEUMATOID ARTHRITIS; SOD3 GENE; TNFA GENE;

ADOLESCENT; ADULT; ALLELES; ARTHRITIS, RHEUMATOID; COHORT STUDIES; FEMALE; GENETIC MARKERS; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HAPLOTYPES; HUMANS; INFLAMMATION; MALE; MEDICINE, AYURVEDIC; MIDDLE AGED; MODELS, GENETIC; ODDS RATIO; OXIDATIVE STRESS; PHENOTYPE; PILOT PROJECTS;

EID: 84866849849     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0045752     Document Type: Article

References (41)

1. Thelma BK (2008) From genomics to 'Ayurgenomics'. In: PHISPC series on History of Science, philosophy and culture in Indian Civilization Volume: Life and Organicism, ed N.S. Rangaswamy, Gen. Editor D.P. Chattopadhyaya.
2. Sharma P (2003) Charaka Samhita (with English translation). Published by Chaukamba Orientalia, Varanasi. 7th Edition -(4 volumes).
3. Susruta Samhita (2000) (Text with english translation). Published by Chaukhamba Visvabharati.
4. Srikanthamurthy KR (2003) Ashtanga hridayam (Text- English translation) Published by Krishnadas Academy, Varanasi (3 volumes).
5. Prasher B, Negi S, Aggarwal S, Mandal AK, Sethi TP, et al. (2008) Indian Genome Variation Consortium, Mukerji M. Whole genome expression and biochemical correlates of extreme constitutional types defined in Ayurveda. J Transl Med. 9: 48.
6. Bhushan P, Kalpana J, Arvind C, (2005) Classification of human population based on HLA gene polymorphism and the concept of Prakriti in Ayurveda. J Altern Complement Med. 11: 349-353.
7. Aggarwal S, Negi S, Jha P, Singh PK, Stobdan T, et al. (2010) EGLN1 involvement in high-altitude adaptation revealed through genetic analysis of extreme constitution types defined in Ayurveda. Proc Natl Acad Sci U S A. 2: 18961-18966.
8. Patwardhan B, (2012) The quest for evidence-based Ayurveda: lessons learned., Current science. 10: 1406-1417.
9. Srikanthamurthy KR (2001) Madhava Nidanam of Madhavakara (Text with English translation), Published by Chaukamba Orientalia, Varanasi.
10. Sethi TP, Prasher B, Mukerji M, (2011) Ayurgenomics: a new way of threading molecular variability for stratified medicine. ACS Chem Biol. 16: 875-880.
11. Hee CS, Gun SC, Naidu R, Gupta E, Somnath SD, et al. (2007) Comparison of single nucleotide polymorphisms in the human interleukin-10 gene promoter between rheumatoid arthritis patients and normal subjects in Malaysia. Mod Rheumatol. 5: 429-435.
12. Fonseca JE, Cavaleiro J, Teles J, Sousa E, Andreozzi VL, et al. (2007) Contribution for new genetic markers of rheumatoid arthritis activity and severity: sequencing of the tumor necrosis factor-alpha gene promoter. Arthritis Res Ther. 2: R37.
13. Ichikawa N, Kotake S, Hakoda M, Higami K, Kawasaki A, et al. (2009) Combining effects of polymorphism of tumor necrosis factor alpha 5′-flanking region and HLA-DRB1 on radiological progression in patients with rheumatoid arthritis. Mod Rheumatol. 2: 134-139.
14. Lee YH, Bae SC, Choi SJ, Ji JD, Song GG, (2012) The association between interleukin-6 polymorphisms and rheumatoid arthritis: a meta-analysis. Inflamm Res. 7: 665-71.
15. Mulcahy B, Waldron-Lynch F, McDermott MF, Adams C, Amos CI, et al. (1996) Genetic variability in the tumor necrosis factor-lymphotoxin region influences susceptibility to rheumatoid arthritis. Am J Hum Genet. 59: 676-683.
16. Fishman D, Faulds G, Jeffery R, Mohamed-Ali V, Yudkin JS, et al. (1998) The effect of novel polymorphisms in the interleukin-6 (IL-6) gene on IL-6 transcription and plasma IL-6 levels, and an association with systemic-onset juvenile chronic arthritis. J Clin Invest. 1: 1369-1376.
17. Buchs N, di Giovine FS, Silvestri T, Vannier E, Duff GW, et al. (2001) IL-1B and IL-1Ra gene polymorphisms and disease severity in rheumatoid arthritis: interaction with their plasma levels. Genes Immun. 2: 222-228.
18. Martinez A, Pascual M, Pascual-Salcedo D, Balsa A, Martin J, et al. (2003) Genetic polymorphisms in Spanish rheumatoid arthritis patients: an association and linkage study. Genes Immun. 4: 117-121.
19. Tamiya G, Shinya M, Imanishi T, Ikuta T, Makino S, et al. (2005) Whole genome association study of rheumatoid arthritis using 27 039 microsatellites. Hum Mol Genet. 15: 2305-2321.
20. Plenge RM, Cotsapas C, Davies L, Price AL, de Bakker PI, et al. (2007) Two independent alleles at 6q23 associated with risk of rheumatoid arthritis. Nat Genet. 39: 1477-1482.
21. The Wellcome Trust Case Control Consortium, (2007) Genome-wide association study of 14,000 cases of seven common diseases and 3,000 shared controls. Nature. 447: 661-678.
22. Harris ML, Darrah E, Lam GK, Bartlett SJ, Giles JT, et al. (2008) Association of autoimmunity to peptidyl arginine deiminase type 4 with genotype and disease severity in rheumatoid arthritis. Arthritis Rheum. 58: 1958-1967.
23. Totaro MC, Tolusso B, Napolioni V, Faustini F, Canestri S, et al. (2011) PTPN22 1858C>T polymorphism distribution in Europe and association with rheumatoid arthritis: case-control study and meta-analysis. PLoS One. 6: e24292.
24. Rodríguez-Rodríguez L, Taib WR, Topless R, Steer S, González-Escribano MF, et al. (2011) The PTPN22 R263Q polymorphism is a risk factor for rheumatoid arthritis in Caucasian case-control samples. Arthritis Rheum. 63: 365-372.
25. Taysi S, Polat F, Gul M, Sari RA, Bakan E, (2002) Lipid peroxidation, some extracellular antioxidants, and antioxidant enzymes in serum of patients with rheumatoid arthritis. Rheumatol Int (5) (): 200-204.
26. Baskol G, Demir H, Baskol M, Kilic E, Ates F, et al. (2005) Assessment of paraoxonase 1 activity and malondialdehyde levels in patients with rheumatoid arthritis. Clin Biochem. 38: 951-955.
27. Afonso V, Champy R, Mitrovic D, Collin P, Lomri A, (2007) Reactive oxygen species and superoxide dismutases: role in joint diseases. Joint Bone Spine. 74: 324-329.
28. Grabar BP, Logar D, Tomsic M, Rozman B, Dolzan V, (2009) Genetic polymorphisms modifying oxidative stress are associated with disease activity in rheumatoid arthritis patients. Dis Markers. 26: 41-48.
29. Naganuma T, Nakayama T, Sato N, Fu Z, Soma M, et al. (2008) Association of extracellular superoxide dismutase gene with cerebral infarction in women: a haplotype-based case-control study.Hereditas. 6: 283-92.
30. Dahabreh IJ, Kitsios GD, Kent DM, Trikalinos TA, (2010) Paraoxonase 1 polymorphisms and ischemic stroke risk: A systematic review and meta-analysis. Genet Med. 10: 606-15.
31. Dasgupta S, Demirci FY, Dressen AS, Kao AH, Rhew EY, et al. (2011) Association analysis of PON2 genetic variants with serum paraoxonase activity and systemic lupus erythematosus. BMC Med Genet. 11: 12-17.
32. Wang M, Lang X, Zou L, Huang S, Xu Z, (2011) Four genetic polymorphisms of paraoxonase gene and risk of coronary heart disease: a meta-analysis based on 88 case-control studies. Atherosclerosis. 2: 377-85.
33. Wruck CJ, Fragoulis A, Gurzynski A, Brandenburg LO, Kan YW, et al. (2011) Role of oxidative stress in rheumatoid arthritis: insights from the Nrf2-knockout mice. Ann Rheum Dis. 70: 844-850.
34. Bauerová K, Bezek A, (1999) Role of reactive oxygen and nitrogen species in etiopathogenesis of rheumatoid arthritis. Gen Physiol Biophys. 18: 15-20.
35. Sarban S, Kocyigit A, Yazar M, Isikan UE, (2005) Plasma total antioxidant capacity, lipid peroxidation, and erythrocyte antioxidant enzyme activities in patients with rheumatoid arthritis and osteoarthritis. Clin. Biochem. 11: 981-986.
36. Arnett FC, Edworthy SM, Bloch DA, McShane DJ, Fries JF, et al. (1988) The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum. 31: 315-324.
37. Stephens M, Smith NJ, Donnelly P, (2001) A new statistical method for haplotype reconstruction from population data. Am J Hum Genet. 68: 978-989.
38. Silman AJ, Pearson JE, (2002) Epidemiology and genetics of rheumatoid arthritis. Arthritis Res. 4: S265-272.
39. Turesson C, Matteson EL, (2006) Genetics of rheumatoid arthritis. Mayo Clin Proc. 81: 94-101.
40. Raychaudhuri S, Remmers EF, Lee AT, Hackett R, Guiducci C, et al. (2008) Common variants at CD40 and other loci confer risk of rheumatoid arthritis. Nat Genet. 40: 1216-1223.
41. van-der-Linden MP, Feitsma AL, le-Cessie S, Kern M, Olsson LM, et al. (2009) Association of a single-nucleotide polymorphism in CD40 with the rate of joint destruction in rheumatoid arthritis. Arthritis Rheum. 60: 2242-2247.